Russia announced that its Sputnik V vaccine against the coronavirus showed 92% effectiveness

A physician simulates what a Covid affected person sees earlier than dying

The physician Kenneth Remy, a physician in Missouri (USA), has recorded a simulation of The very last thing a affected person who dies from...

Restoration plan: cash on the desk, blurring of imaginative and prescient

Restore coloration to our financial system and our society. That is the target of the “restoration and resilience plan” that Belgium should hand...

‘English hospitals will obtain corona vaccine from Pfizer in per week and a half’

The UK department of the UK nationwide well being service NHS has advised hospitals that from December 7 they may have vaccines developed and...

Uruguay: former president Tabaré Vázquez, in ‘delicate state of well being’

The previous president suffered a relapse linked to most cancers that was identified in 2019.The previous president of Uruguay Tabaré Vázquez is in a...

‘English hospitals will obtain corona vaccine from Pfizer from December 7’

The UK department of the UK nationwide well being service NHS has informed hospitals that from December 7 they may have vaccines developed and...

This was confirmed by the Gamaleya Center in Moscow, which carried out the development. Argentina agreed to purchase 25 million doses.

The Russian government announced Wednesday that the Sputnik V coronavirus vaccine, developed at the Gamaleya center, showed an effectiveness of 92%, which allows to start the massive application in the coming weeks.

This is the development by which Argentina agreed with the government of Vladimir Putin to purchase 25 million doses, which will be able to vaccinate 12.5 million people, since it requires two applications.

According to official information, “the trials evaluated efficacy among more than 16,000 volunteers who received the vaccine or placebo 21 days after the first injection.”

“As a result of a statistical analysis of 20 confirmed cases of coronavirus, the division of cases between vaccinated people and those who received the placebo indicates that the Sputnik V vaccine had an efficacy rate of 92% after the second dose,” he says The report.

In addition, always according to official information, the vaccine was tested in September in a group of volunteers from the “red zones” of Russian hospitals.

“Observation of 10,000 additional vaccinated volunteers representing physicians and other high-risk groups under civilian use of the vaccine outside of clinical trials also confirmed the vaccine’s efficacy rate of more than 90 percent,” they said.

Among the volunteers, no significant adverse effects were recorded. Some of the vaccinated reported injection site pain, flu-like syndrome including fever, weakness, fatigue, and headache.

Days ago, President Alberto Fernández announced an agreement with his Russian counterpart, Vladimir Putin, for the purchase of 25 million doses of this vaccine, once it is approved. According to the president himself, the first batch would arrive in December and the second in January.

News in development.

JPE

trending

Related Articles